Clinical Trial Update: Study of a Tetravalent Meningococcal Diphtheria Toxoid Conjugate Vaccine in Toddlers 9 to 18 Months of Age [Phase 2]

View source ↗

Summary

Phase 2 study of a tetravalent meningococcal diphtheria toxoid conjugate vaccine in toddlers aged 9 to 18 months. The study is completed with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Meningococcal Disease
• Meningitis

Drugs mentioned

• MenACWY-D (Meningococcal conjugate vaccine, quadrivalent (diphtheria toxoid conjugate))

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Meningitis, Meningococcal Infection | Phase 2 | Status: COMPLETED | Results posted: 2010-01-08